Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones

European Journal of Neuroscience

Volumn 32, Issue 3, 2010, Pages 359-367

  Suarez F ^a,b   Zhao, Q ^a   Monaghan, D T ^c   Jane, D E ^d   Jones, S ^b   Gibb, A J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

excitotoxicity; glutamate receptor; ifenprodil; Parkinson's disease; triheteromeric

Indexed keywords

ADENOSINE TRIPHOSPHATE; GUANOSINE TRIPHOSPHATE; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RECEPTOR SUBUNIT; UBP 141; UNCLASSIFIED DRUG; ZINC ION;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CELL DEATH; CONTROLLED STUDY; DESENSITIZATION; DOPAMINERGIC NERVE CELL; DRUG SENSITIVITY; EXCITOTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SUBSTANTIA NIGRA;

ANIMALS; ANIMALS, NEWBORN; DOPAMINE; ELECTROPHYSIOLOGY; N-METHYLASPARTATE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANTIA NIGRA;

EID: 77955129538     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2010.07298.x     Document Type: Article

References (59)

1. Bergman, H., Wichmann, T., Karmon, B. DeLong, M.R. (1994) The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of Parkinsonism. J. Neurophysiol., 72, 507 520.
2. Blandini, F., Nappi, G., Tassorelli, C. Martignoni, E. (2000) Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog. Neurobiol., 62, 63 88.
3. Bolam, J.P., Hanley, J.J., Booth, P.A. Bevan, M.D. (2000) Synaptic organisation of the basal ganglia. J. Anat., 196, 527 542.
4. Brickley, S.G., Misra, C., Mok, M.H., Mishina, M. Cull-Candy, S.G. (2003) NR2B and NR2D subunits coassemble in cerebellar Golgi cells to form a distinct NMDA receptor subtype restricted to extrasynaptic sites. J. Neurosci., 23, 4958 4966.
5. Brothwell, S.L.C., Barber, J.L., Monaghan, D.T., Jane, D.E., Gibb, A.J. Jones, S. (2008) NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones. J. Physiol., 586, 739 750.
6. Chan, C.S., Gertler, T.S. Surmeier, D.J. (2009) Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci., 32, 249 256.
7. Chazot, P.L. Stephenson, F.A. (1997) Molecular dissection of native mammalian forebrain NMDA receptors containing the NR1 C2 exon: direct demonstration of NMDA receptors comprising NR1, NR2A and NR2B subunits within the same complex. J. Neurochem., 69, 2138 2144.
8. Chazot, P.L., Lawrence, S. Thompson, C.L. (2002) Studies on the subtype selectivity of CP-101,606: evidence for two classes of NR2B-selective NMDa receptor antagonists. Neuropharmacology, 42, 319 324.
9. Choi, D.W. (1988) Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci., 11, 465 469.
10. Cull-Candy, S.G. Leszkiewicz, D.N. (2004) Role of distinct NMDA receptor subtypes at central synapses. Sci. STKE, 2004, re16.
11. Dravid, S.M., Prakash, A. Traynelis, S.F. (2008) Activation of recombinant NR1/NR2C NMDA receptors. J. Physiol., 586, 4425 4439.
12. Dempster, J. (2001) The Laboratory Computer: A Practical Guide for Physiologists and Neuroscientists. Academic Press, London, UK.
13. Dunah, A.W., Luo, J., Wang, Y.H., Yasuda, R.P. Wolfe, B.B. (1998) Subunit composition of N-methyl-d-aspartate receptors in the central nervous system that contain the NR2D subunit. Mol. Pharmacol., 53, 429 437.
14. Edwards, F.A., Konnerth, A., Sakmann, B. Takahashi, T. (1989) A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system. Pflugers Arch., 414, 600 612.
15. Forder, J.P. Tymianski, M. (2009) Postsynaptic mechanisms of excitotoxicity: involvement of postsynaptic density proteins, radicals, and oxidant molecules. Neuroscience, 158, 293 300.
16. Gardoni, F. Di Luca, M. (2006) New targets for pharmacological intervention in the glutamatergic synapse. Eur. J. Pharmacol., 545, 2 10.
17. Grace, A.A. Bunney, B.S. (1984a) The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci., 4, 2877 2890.
18. Grace, A.A. Bunney, B.S. (1984b) The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci., 4, 2866 2876.
19. Groc, L., Heine, M., Cousins, S.L., Stephenson, F.A., Lounis, B., Cognet, L. Choquet, D. (2006) NMDA receptor surface mobility depends on NR2A-2B subunits. Proc. Natl Acad. Sci. USA, 103, 18769 18774.
20. Hallett, P.J. Standaert, D.G. (2004) Rationale for and use of NMDA receptor antagonists in Parkinson's disease. Pharmacol. Ther., 102, 155 174.
21. Hardingham, G.E. Bading, H. (2003) The Yin and Yang of NMDA receptor signalling. Trends Neurosci., 26, 81 89.
22. Hardman, C.D., McRitchie, D.A., Halliday, G.M., Cartwright, H.R. Morris, J.G.L. (1996) Substantia nigra pars reticulata neurons in Parkinson's disease. Neurodegeneration, 5, 49 55.
23. Hatton, C.J. Paoletti, P. (2005) Modulation of triheteromeric receptors by N-terminal domain ligands. Neuron, 46, 261 274.
24. Hikosaka, O. Wurtz, R.H. (1985) Modification of saccadic eye movements by GABA-related substances. II. Effects of muscimol in monkey substantia nigra pars reticulata. J. Neurophysiol., 53, 292 308. (Pubitemid 15174289)
25. Hikosaka, O., Takikawa, Y. Kawagoe, R. (2000) Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol. Rev., 80, 953 978.
26. Ibanez-Sandoval, O., Carrillo-Reid, L., Galarraga, E., Tapia, D., Mendoza, E., Gomora, J.C., Aceves, J. Bargas, J. (2007) Bursting in substantia nigra pars reticulata neurons in vitro: possible relevance for Parkinson disease. J. Neurophysiol., 98, 2311 2323.
27. Johnson, S.W. North, R.A. (1992) Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol., 450, 455 468.
28. Jones, S. Gibb, A.J. (2005) Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones. J. Physiol., 569, 209 221.
29. Kemp, J.A. McKernan, R.M. (2002) NMDA receptor pathways as drug targets. Nat. Rev. Neurosci., 5 (Suppl 1039 1042.
30. Köhr, G., Eckardt, S., Lüddens, H., Monyer, H. Seeburg, P.H. (1994) NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron, 12, 1031 1040.
31. Krupp, J.J., Vissel, B., Heinemann, S.F. Westbrook, G.L. (1996) Calcium-dependent inactivation of recombinant N-methyl-d-aspartate receptors is NR2 subunit specific. Mol. Pharmacol., 50, 1680 1688.
32. Lau, C.G. Zukin, R.S. (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci., 8, 413 426.
33. Lin, J.Y. Lipski, J. (2001) Dopaminergic substantia nigra neurons express functional nmda receptors in postnatal rats. J. Neurophysiol., 85, 1336 1339.
34. MacDonald, J.F., Mody, I. Salter, M.W. (1989) Regulation of N-methyl-d-aspartate receptors revealed by intracellular dialysis of murine neurones in culture. J. Physiol., 414, 17 34.
35. Margolis, E.B., Lock, H., Hjelmstad, G.O. Fields, H.L. (2006) The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? J. Physiol., 577, 907 924.
36. Martel, M.A., Wyllie, D.J.A. Hardingham, G.E. (2009) In developing hippocampal neurons, NR2B-containing N-methyl-d-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience, 158, 334 343.
37. Mereu, G., Costa, E., Armstrong, D.M. Vicini, S. (1991) Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices. J. Neurosci., 11, 1359 1366.
38. Monyer, H., Burnashev, N., Laurie, D.J., Sakmann, B. Seeburg, P.H. (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron, 12, 529 540.
39. Morley, R.M., Tse, H.W., Feng, B., Miller, J.C., Monaghan, D.T. Jane, D.E. (2005) Synthesis and pharmacology of N1-substituted piperazine-2,3- dicarboxylic acid derivatives acting as NMDA receptor antagonists. J. Med. Chem., 48, 2627 2637.
40. Mott, D.D., Doherty, J.J., Zhang, S., Washburn, M.S., Fendley, M.J., Lyuboslavsky, P., Traynelis, S.F. Dingledine, R. (1998) Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition. Nat. Neurosci., 1, 659 667.
41. Newpher, T.M. Ehlers, M.D. (2008) Glutamate receptor dynamics in dendritic microdomains. Neuron, 58, 472 497.
42. Obeso, J.A., Rodriguez-Oroz, M.C., Rodriguez, M., Lanciego, J.L., Artieda, J., Gonzalo, N. Olanow, C.W. (2000) Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci., 23, S8 S19.
43. Paoletti, P. Neyton, J. (2007) NMDA receptor subunits: function and pharmacology. Curr. Opin. Pharmacol., 7, 39 47.
44. Pérez-Otaño, I. Ehlers, M.D. (2005) Homeostatic plasticity and NMDA receptor trafficking. Trends Neurosci., 28, 229 238.
45. 2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons. J. Neurosci., 29, 15414 15419.
46. 2+ and ATP. J. Physiol., 470, 705 729.
47. Rosenmund, C., Feltz, A. Westbrook, G.L. (1995) Calcium-dependent inactivation of synaptic NMDA receptors in hippocampal neurons. J. Neurophysiol., 73, 427 430.
48. Soriano, F.X. Hardingham, G.E. (2007) Compartmentalized NMDA receptor signalling to survival and death. J. Physiol., 584, 381 387.
49. Soriano, F.X., Martel, M.A., Papadia, S., Vaslin, A., Baxter, P., Rickman, C., Forder, J., Tymianski, M., Duncan, R., Aarts, M., Clarke, P., Wyllie, D.J. Hardingham, G.E. (2008) Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J. Neurosci., 28, 10696 10710.
50. Stephenson, F.A., Cousins, S.L. Kenny, A.V. (2008) Assembly and forward trafficking of NMDA receptors. Mol. Membr. Biol., 25, 311 320.
51. Surmeier, D.J., Guzman, J.N. Sanchez-Padilla, J. 2010) Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease. Cell Calcium. 47, 175 182.
52. Tovar, K.R. Westbrook, G.L. (1999) The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci., 19, 4180 4188.
53. Villarroel, A., Regalado, M.P. Lerma, J. (1998) Glycine-independent NMDA receptor desensitization: localization of structural determinants. Neuron, 20, 329 339.
54. Villmann, C. Becker, C.-M. (2007) On the hypes and falls in neuroprotection: targeting the NMDA receptor. Neuroscientist, 13, 594 615.
55. 2+] and is prevented by ATP in rat spinal dorsal horn neurons. Neurosci. Lett., 157, 183 186.
56. Williams, K. (1993) Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol., 44, 851 859.
57. Williams, M.N. Faull, R.L. (1985) The striatonigral projection and nigrotectal neurons in the rat: a correlated light and electron microscopic study demonstrating a monosynaptic striatal input to identified nigrotectal neurons using a combined degeneration and horseradish peroxidase procedure. Neuroscience, 14, 991 1010.
58. Wu, Y.N. Johnson, S.W. (1996) Pharmacological characterization of inward current evoked by N-methyl-d-aspartate in dopamine neurons in the rat brain slice. J. Pharmacol. Exp. Ther., 279, 457 463.
59. Wyllie, D.J., Behe, P. Colquhoun, D. (1998) Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors. J. Physiol., 510, 1 18.